Company: APXIF
Filing Date: 2025-07-03
Form Type: F-4/A
Source: 0001213900-25-061545
Chunk: 236

Company: APx Acquisition Corp. I
Filing Date: 2025-07-03
Form: F-4/A
Chunk 236
---
 the IPO, was previously compensated for underwriting services in connection with the IPO and was to be compensated further, on a deferred basis, for already -rendered underwriting services in connection with the IPO, yet BofA, without any consideration from APx or the Company, waived its entitlement to such compensation solely with respect to the Business Combination and disclaimed any responsibility for this proxy statement / prospectus, but BofA remains entitled to customary indemnification and contribution obligations of APx in connection with the IPO. BofA Securities, Inc, the underwriter in the IPO, was previously compensated in the aggregate amount of $3,450,000 for underwriting services in connection with the IPO and was to be compensated further in the aggregate amount of $6,037,500, on a deferred basis, for already -renderedunderwriting services in connection with the IPO, in connection with the closing of APx’s initial business combination. BofA did not identify any of the Potential Targets or participate in the due diligence regarding the Company. BofA has had no involvement in the proposed Business Combination and did not assist in (i) identifying or procuring the Company as a target business, (ii) developing any financial models or other evaluation materials relating to the Company or the Business Combination, (iii) marketing the Business Combination, (iv) preparing or reviewing this proxy statement/prospectus or any of the disclosure contained herein or (v) any other role in the Business Combination. Representatives of APx initiated discussions with representatives from BofA to discuss BofA’s deferred underwriting compensation given the lack of any role to be performed by BofA in the proposed Business Combination. On September 28, 2022, BofA delivered to APx a notice waiving its entitlement to the payment of its deferred underwriting fee with respect to the Business Combination with the Company, declining to serve in any capacity in connection with the Business Combination with the Company, confirming that it does not have any role with respect to the Business Combination with the Company and disclaiming any responsibility for any portion of this proxy statement/prospectus. BofA communicated to APx its decision to waive its deferred underwriting fee with respect to the Business Combination was due to market and regulatory uncertainty relating to special purpose acquisition company business combination transactions in general BofA received no additional consideration for the waiver of its entitlement to the payment of the deferred underwriting fee with respect to the Business Combination. 97 APx believes that a gratuitous